Medicines Australia
Medicines Australia promotes the interests of the pharmaceutical industry by encouraging a favourable investment environment, working on behalf of its members in an advocacy and consultative capacity with government and non-government organisations.
Through Medicines Australia, GSK can shape a more positive external environment where the value of innovation is recognised and patient access to GSK products is not unduly constrained.
Medicine’s Australia announced at its Annual General Meeting this year that GSK’s Managing Director Paul Lirette will be appointed to its Board of Directors.
|
